While they’re generally safe for consumption, some individuals may suffer from negative effects like digestive problems, inflammation, and autoimmune reactions due to lectin intake. As a result ...

Omeros’ lead MASP-2 inhibitor narsoplimab targets the lectin pathway of complement and is the subject of a biologics license application pending before FDA for the treatment of hematopoietic ...

Valora's AbLec (Antibody-Lectin chimera) platform is expected to offer a fresh perspective on restoring proper immunological competency. By precisely targeting specific sugar molecules on cells ...